RAND: U.S. should pilot supervised injection sites, heroin-assisted treatment
December 06, 2018 / Paige Minemyer
Positive results from supervised injection sites and heroin-assisted treatment (HAT) abroad suggest it’s time for U.S. policymakers to consider piloting similar programs stateside, according to a new report. A new study from RAND Corporation suggests these controversial treatment options are viable for patients with opioid use disorder that’s resistive to traditional medication-assisted treatment (MAT) options like methadone or buprenorphine. Though boosting access to MAT should be the central priority, RAND’s researchers said that because the opioid epidemic is so widespread—and deadly street drugs like fentanyl are proliferating—it’s important to explore all potential options for addressing the problem.